Physician profile
Josh S Baek
NPI 1568768323
$781.61
in general payments reported to CMS, 2019-2025
18 companies · $51.06 in 2025
The $51.06 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $54.56 · 2021: $107 · 2022: $22.09 · 2023: $392 · 2024: $155 · 2025: $51.06.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $598.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $597.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $223.54 | 2020-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $70.38 | 2021-2023 | Qulipta |
| Glaxosmithkline, LLC. | $61.93 | 2023-2024 | Trelegy Ellipta, Arexvy, Shingrix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $57.95 | 2021-2023 | Spiriva Respimat, Stiolto Respimat, Jardiance |
| Amgen INC. | $51.28 | 2021-2023 | Repatha |
| Almatica Pharma LLC | $49.42 | 2023 | Loreev Xr, Gralise |
| Merck Sharp & Dohme LLC | $37.25 | 2023 | Gardasil 9, Pneumovax 23, Vaxneuvance |
| Lilly USA, LLC | $29.77 | 2021-2023 | Emgality, Jardiance |
| Exact Sciences Corporation | $28.33 | 2024 | Cologuard Collection Kit |
| Alexion Pharmaceuticals, INC. | $25.70 | 2023 | Soliris |
| Zealand Pharma US, INC. | $22.00 | 2021 | |
| Gilead Sciences, INC. | $20.35 | 2023 | |
| Pfizer INC. | $19.78 | 2023 | |
| Kowa Pharmaceuticals America, INC. | $19.28 | 2023 | Livalo, Seglentis |
| Phadia US INC. | $17.61 | 2023 | Immunocap |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Xeris Pharmaceuticals, INC. | $17.36 | 2023 | Gvoke Hypopen |
| Boston Scientific Corporation | $16.47 | 2023 | Lux-Dx Insertable Cardiac Monitor |
| Ibsa Pharma INC. | $13.21 | 2023 | Tirosint, Licart |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Josh Baek listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.